4 - 4 |
Crunch point [Anonymous] |
5 - 5 |
Chemistry celebrations Runge T |
6 - 7 |
First gene-edited babies born, scientist claims Scientists and ethicists broadly criticize experiment Cross R, Mullin R, Satyanarayana M, Tremblay JF |
8 - 8 |
Monitoring water quality after wildfires Researchers are just starting to study how blazes like California's devastating Camp Fire may contaminate watersheds Bourzac K |
9 - 9 |
Vast variability found in Alzheimer's gene Satyanarayana M |
9 - 9 |
Nobel laureate Aaron Mug dies OBITUARY Howes L |
10 - 10 |
Phytane reveals Earth's carbon history Katsnelson A |
10 - 10 |
Nanoparticles clean wastewater Halford B |
11 - 11 |
Methylating agents damage DNA Arnaud C |
11 - 11 |
Tracking ion transport in radical polymers Jacoby M |
11 - 11 |
Smart-speaker science showdown Jones S |
12 - 12 |
Air Liquide plans H-2 for energy market Reisch M |
12 - 12 |
Low-flowing Rhine shuts BASF plant Chemical companies are affected up and down the European river Scott A |
13 - 13 |
Bayer to cut 12,000 jobs, animal health business Scott A |
14 - 14 |
FDA clears a tissue-agnostic cancer drug Bayer and Loxo's treatment will carry a hefty price tag Jarvis LM |
15 - 15 |
Aramco pledges $100 billion in chemical investment Tullo A |
15 - 15 |
Ethylene oxide leak shuts down bridge Reisch M |
15 - 15 |
Crunch time for Brexit Scott A |
15 - 15 |
Toray plans suede with green content Tremblay JF |
15 - 15 |
Bain, Piramal invest in brine chemicals Tremblay JF |
15 - 15 |
Corona will ditch plastic 6-pack rings Tullo A |
15 - 15 |
Exxon's Chapman will receive SCI medal Tullo A |
16 - 16 |
Rheostat emerges, targets neuroscience Jarvis LM |
16 - 16 |
Genentech buys liver disease firm Jecure Jarvis LM |
16 - 16 |
WuXi launches Irish database project Mullin R |
16 - 16 |
Software group takes on force field models Mullin R |
16 - 16 |
Bruker to acquire Austrian imaging firm Reisch M |
16 - 16 |
Business Roundup [Anonymous] |
17 - 17 |
North Carolina strikes deal with Chemours Hogue C |
17 - 17 |
Data lacking on safety of treated sewage sludge Hogue C |
18 - 20 |
The heat is on Hogue C |
24 - 25 |
Civica Rx aims to shake up the generics market Jarvis LM |
26 - 27 |
Teaching for the labs of the future Lemonick S |
32 - 32 |
A very good year for RNA therapeutics [Anonymous] |
33 - 33 |
FDA chief pushed hard on public health issues Mullin E |
34 - 34 |
Biotech IPO climate was hot Jarvis LM |
35 - 35 |
Gender diversity in the spotlight Jarvis LM |
36 - 36 |
CRISPR's controversies Cross R |
37 - 37 |
M&A activity disappointed Jarvis LM |
38 - 39 |
A bountiful year for biotech start-ups Jarvis LM |
40 - 40 |
A therapy went from speculative to sizzling Cross R |
41 - 41 |
Cannabis flourished for pharma Halford B |
42 - 42 |
Oncolytic virus therapies heated up Cross R |
43 - 43 |
ACS financial guidelines: A dashboard of the society's health Heppert J |
44 - 44 |
ACS Shanghai chapter cohosts inaugural medicinal chemistry conference Nguyen T |
48 - 48 |
The advent of chemistry Scott A |
48 - 48 |
Making a chemistree [Anonymous] |